Health News

Macular Degeneration Rx: A Closer Look
Before anti-VEGF medications like Avastin (bevacizumab) and Lucentis (ranibizumab), patients with age-related macular degeneration (AMD) had much worse outcomes, a new study found.
How Statins Might Help Your Sight
Statins are known to lower cholesterol and improve heart health in some patients. New evidence suggests they could also help some patients' sight.
Sunglasses: Looking Cooler and Staying Healthier
Sunglasses can do more than make you look like a movie star — they can also help protect your eyes from the sun's harmful rays.
Common Diabetes Rx Might Be a Sight-Saver
It’s always nice to get a clear view. One diabetes medication may help patients do just that.
When Too Much Calcium Might Be a Bad Thing
If a supplement is good for, say, bone health, most people would feel wise to use it. However, the situation can get sticky when that same supplement is tied to an increased risk of other health issues.
Another Option to Treat Diabetic Retinopathy
There's a new, FDA-approved treatment for diabetic retinopathy.
New Treatment for Diabetic Retinopathy
The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.
Blacks May Have Higher Risk for Diabetic Vision Loss
Diabetes affects more than 300 million people around the world and has many negative effects, including a higher risk of hypertension, stroke and even vision loss. And a new study suggests blacks may be more at risk for diabetic vision loss.
Macular Degeneration May Affect Younger Age Group
Macular degeneration is a common cause of visual impairment and blindness in the elderly. But recent research suggests this disorder can also be found in much younger people.
Inactivity a Major Issue for Adults with Disabilities
Staying physically active is important for everyone, even for adults who cope with disabilities. And a new report suggests that many of these adults aren't getting enough activity.